Ovid Therapeutics (OVID) Tax Rate (2021 - 2022)
Ovid Therapeutics' (OVID) quarterly Tax Rate came in at 0.31% in Q1 2022, down 59.0% YoY from 0.76% in Q1 2021, and down 123.46% on a QoQ basis from 1.33% in Q4 2021.
Ovid Therapeutics (OVID) Tax Rate (2021 - 2022) Analysis & Trends
Ovid Therapeutics (OVID) has 2 years of Tax Rate data on file, last reported at 0.31% in Q1 2022.
- Quarterly Tax Rate fell 59.0% year-over-year to 0.31% in Q1 2022, while the trailing twelve-month figure through Dec 2022 was 0.09% (down 116.0% YoY) and the FY2021 annual result came in at 1.07%, changed N/A from the prior year.
- Tax Rate eased to 0.31% in Q1 2022, from 1.33% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 2.52% in Q3 2021 to a low of 10.29% in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -0.31% |
| Mar 31, 2022 | -0.31% |
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | 1.33% |
| Dec 31, 2021 | 1.33% |
| Dec 31, 2021 | 1.33% |
| Sep 30, 2021 | 2.52% |
| Sep 30, 2021 | 2.52% |
| Sep 30, 2021 | 2.52% |
| Jun 30, 2021 | -10.29% |
| Jun 30, 2021 | -10.29% |
| Jun 30, 2021 | -10.29% |
| Mar 31, 2021 | 0.28% |
| Mar 31, 2021 | 0.28% |
| Mar 31, 2021 | 0.28% |